Skip to content

Opioids

IMS Opioids Initiative

Over the past 10 years, the rate of opioid overdose deaths in Iowa has more than tripled. As our state seeks to address this growing problem, Iowa physicians must on the forefront. This resource page has been developed to help prescribers access the resources necessary to grow their medical knowledge and lead efforts to combat opioid abuse, while continuing to provide high-quality care to their patients.

* Course is being updated to reflect the 2022 update to the CDC Prescribing Guidelines. Updated link will be available mid-September.

Click to begin online training modules.

Learning Objectives:

  1. Determine when initiation or continuation of opioids is indicated in the treatment of chronic pain.
  2. Evaluate and mitigate risk related to opioid use through dose limitations, clinical reassessment, and monitoring tools like the prescription drug monitoring program and urine drug testing.
  3. Identify quality measures applicable to their clinical practices to assess implementation of the CDC guidelines.

CME Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Iowa Carver College of Medicine and the Iowa Department of Public Health. The Carver College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Iowa Carver College of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There is no charge for the course, but registration is required.

This educational program and associated CME credits are provided at no charge courtesy of the Iowa Department of Public Health and the Opioid Response Network funded by SAMHSA.


Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Disclosure Policy
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest.

Financial Disclosures
Planners and faculty of this activity disclosed no relevant financial relationships.

Anthony Miller
Deborah Richardson
Anureet Walia
Monica Wilke-Brown

References:  References CDC Guidelines for Opioid Prescribing Course.pdf

Scroll To Top